Acurx Pharmaceuticals Inc (ACXP)
followers
·
Follow
| Sector: | HEALTH CARE |
| Industry: | BIOTECHNOLOGY & LIFE SCIENCES |
| SIC: | PHARMACEUTICAL PREPARATIONS |
| CEO: | David P. Luci |
| Employees: | 3 |
| Web site: | www.acurxpharma.com |
|
259 LIBERTY AVENUE, STATEN ISLAND, NY, 10305
917-533-1469
| |
| All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
|---|
Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. Its lead antibiotic candidate is ibezapolstat, a novel mechani® of action that targets the polymerase IIIC enzyme. The company is also developing ACX-375C, a potential oral and parenteral treatment targeting gram-positive bacteria.
Please log in first to see chart